1600 Divisadero Street, San Francisco, CA 94115
The University of California’s San Francisco (UCSF) campus is exclusively dedicated to patient care, medical education and specialized health research. Three campuses in Parnassus Heights, Mission Bay and Mount Zion compose the facilities for the UCSF Medical Center. UCSF has also partnered with San Francisco General Hospital since 1873. Together these facilities offer top-notch health care to mesothelioma patients living in or near the San Francisco area.
The UCSF Helen Diller Family Comprehensive Cancer Center is where most mesothelioma patients are referred. This facility is the only National Cancer Institute (NCI)-designated comprehensive cancer institute in northern California.
At the Helen Diller Comprehensive Cancer Center, mesothelioma patients can benefit from the thoracic surgery and oncology ward. David Jablons, M.D., professor and chief of the Section of General Thoracic Surgery, earned a grant from the National Institutes of Health for his investigation of a pathway used in the treatment of mesothelioma. Mesothelioma specialists Thierry Jahan, M.D., and Shayne Cardozo (a lung surgery nurse coordinator who specializes in mesothelioma) are also employed at the UCSF Medical Center. Under the supervision of these specialists and their colleagues, patients with asbestos-related diseases can receive care that optimizes their chances of survival, including imaging scans, biopsies, surgeries and palliative care.
Radiation oncology is also a major clinic at the UCSF Medical Center where mesothelioma patients may visit if referred by their primary physician. Offered at the Mount Zion and Parnassus campuses, the radiation oncology wards incorporate evidence-based medicine with emergent care techniques. Treatments featured at the UCSF department of radiation oncology include gamma knife radiation therapy and intensity-modulated radiation therapy.
UCSF patients benefit from the leading technologies created and utilized at the medical center. This includes more than 600 patents for medical advancements between 2000 and 2009, indicating a high focus on delivering cutting-edge technologies and procedures to patients. For years UCSF has been a leading public recipient of research support from the National Institutes of Health. It also receives upwards of $166 million in funding from the American Recovery and Reinvestment Act. Currently, UCSF is involved with roughly 1,000 investigative clinical trials.
Uniting some of the nation’s leading specialists with breakthrough treatments and unique clinical trials, UCSF is fully prepared to offer mesothelioma patients some of the best medical care in the country.
With one of the nation’s best programs in patient care, over 763,000 patients turn to the hospital’s outpatient services each year, while the buildings also accommodate more than 700 inpatient clients at a time. For 10 years in a row U.S. News and World Reportranked UCSF as one of the top 10 hospitals in the country. In 2011, it was ranked seventh.
The Mission Bay campus is scheduled to open a cancer ward in 2014, and they currently operate a cancer center under its own affiliation.
View our resources for patients and familiesGet Help Today